Sub‐retinal neovascular membrane in exudative macular degeneration

REFERENCES

• Soubrane G, Bressler NM. Treatment of subfoveal choroidal neovascularisation in age‐related macular degeneration: focus on clinical application of verteporfin photo dynamic therapy. Br J Ophthalmol 2001; 85: 483–495.
   Web of Science ®Google Scholar
• Evans J, Wormald R. Is the incidence of registrable age‐related macular degeneration increasing Br J Ophthalmol 1996; 80: 9–14.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age‐related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450–1460.
   PubMed Web of Science ®Google Scholar
• Wolffsohn J. The changing face of the visually impaired: The Kooyong low vision clinical past, present and future. Optom Vis Sci 1999; 76: 747–754.
   PubMed Web of Science ®Google Scholar
• Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD et al. An international classification and grading system for age‐related maculopathy and age‐related macular degeneration. Surv Ophthalmol 1995; 39: 367–374.
   PubMed Web of Science ®Google Scholar
• Klein R, Davis MD, Magli YL, Segai P, Klein BEK, Hubbard L. The Wisconsin age‐related maculopathy grading system. Ophthalmology 1991; 98: 1128–1134.
   PubMed Web of Science ®Google Scholar
• Ferris FL, Fine SL, Hyman L. Age‐related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984; 102: 1640–1642.
   PubMed Web of Science ®Google Scholar
• Macular Photocoagulation Study Group. Five‐year follow up of fellow eyes of patients with age‐related macular degeneration and unilateral extrafoveal choroidal neovascularisation. Arch Ophthalmol 1993; 111: 189–199.
   Google Scholar
• Sickenberg M. Early detection, diagnosis and management of choroidal neovascularisation in age related macular degeneration: The role of ophthalmologists. Ophthalmalogical 2001; 215: 247–253.
   PubMed Web of Science ®Google Scholar
• Ciulla TA, Danis RP, Harris A. Age‐related macular degeneration: A review of experimental treatments. Surv Ophthalmol 1998; 43: 134–146.
   PubMed Web of Science ®Google Scholar
• Fine SL. Editorial. Photodynamic therapy with verteporfin is effective for selected patients with neovascular age‐related macular degeneration. Arch Ophthalmol 1999; 117: 1400–1402.
   Google Scholar
• Bressler SB, Bressler NM, Fine SL, Hillis A, Murphy RP, Olk RJ et al. Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degneration. Am J Ophthalmol 1982; 93: 157–163.
   PubMed Web of Science ®Google Scholar
• Rhee DJ, Pyfer, MF, eds. The Wills Eye Manual—Office and emergeney room diagnosis and treatment of eye disease, 3rd ed. Philadelphia : Lillincott, Williams and Wilkins; 1999.
   Google Scholar
• Young RW. Pathophysiology of age‐related macular degeneration. Surv Ophthalmol 1987; 31: 291–306.
   PubMed Web of Science ®Google Scholar
• Green WR, Enger C. Age‐related macular degeneration histopathologic studies. Ophthalmology 1993; 100: 1519–1535.
   PubMed Web of Science ®Google Scholar
• Mccarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor HR. Risk factors for age‐related maculopathy. The Visual Impairment Project. Arch Ophthalmol 2001; 119: 1455–1462.
   PubMed Web of Science ®Google Scholar
• Schwartz SD. Age‐related maculopathy and age‐related macular degeneration. In: Silverston B, Rosenthal BP, Lang MA, Faye, EE, eds. The Lighthouse Handbook on Vision Impairment and Vision Rehabilitation: Vol 1. Vision Impairment. Oxford : Oxford University Press; 2000: 83–101.
   Google Scholar
• Mandal N, Chisholm IH. Identifying the proportion of age related macular degeneration patients who would benefit from photodynamic therapy with verteporfin (Visudyne). Br J Ophthalmol 2002; 86: 118–119.
   Web of Science ®Google Scholar
• The Age‐Related Eye Disease Study Group. A randomized, placebo‐controlled, clinical trial of high dose supplementation with vitamins C and E, beta carotene, and zinc for age‐related macular degeneration and vision loss: AREDS report No. 1. Arch Ophthalmol 2001; 119: 1417–1436.
   Google Scholar
• Jampol LM. Editorial. Antioxidants, zinc and age‐related macular degeneration. Arch Ophthalmol 2001; 119: 1533–1534.
   Google Scholar